Loading...
Collegium Pharmaceutical, Inc.
COLL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$31.78
$-0.33(-1.03%)
Collegium Pharmaceutical, Inc. (COLL) Financial Performance & Income Statement Overview
Review Collegium Pharmaceutical, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
11.41%
↑ 11.41%
Operating Income Growth
1.76%
↑ 1.76%
Net Income Growth
43.68%
↑ 43.68%
Operating Cash Flow Growth
-25.39%
↓ 25.39%
Operating Margin
21.39%
↑ 21.39%
Gross Margin
57.69%
↑ 57.69%
Net Profit Margin
6.61%
↑ 6.61%
ROE
19.21%
↑ 19.21%
ROIC
12.41%
↑ 12.41%
Collegium Pharmaceutical, Inc. (COLL) Income Statement & Financial Overview
Review Collegium Pharmaceutical, Inc.'s (COLL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $181.95M | $159.30M | $145.28M | $144.92M |
| Cost of Revenue | $83.66M | $62.51M | $54.47M | $53.47M |
| Gross Profit | $98.29M | $96.79M | $90.81M | $91.46M |
| Gross Profit Ratio | $0.54 | $0.61 | $0.63 | $0.63 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $63.09M | $61.95M | $43.34M | $41.98M |
| Operating Expenses | $60.18M | $61.95M | $43.34M | $41.98M |
| Total Costs & Expenses | $146.75M | $124.46M | $97.81M | $95.45M |
| Interest Income | $1.81M | $3.28M | $4.40M | $4.49M |
| Interest Expense | $22.65M | $18.39M | $15.59M | $17.34M |
| Depreciation & Amortization | -$1.81M | $41.75M | $35.47M | $35.43M |
| EBITDA | $38.11M | $75.72M | $80.15M | $89.39M |
| EBITDA Ratio | $0.21 | $0.48 | $0.55 | $0.62 |
| Operating Income | $38.11M | $34.84M | $47.47M | $49.47M |
| Operating Income Ratio | $0.21 | $0.22 | $0.33 | $0.34 |
| Other Income/Expenses (Net) | -$20.84M | -$19.26M | -$18.37M | -$12.85M |
| Income Before Tax | $17.27M | $15.58M | $29.10M | $36.62M |
| Income Before Tax Ratio | $0.09 | $0.10 | $0.20 | $0.25 |
| Income Tax Expense | $4.73M | $6.25M | $9.49M | $8.91M |
| Net Income | $12.54M | $9.34M | $19.61M | $27.71M |
| Net Income Ratio | $0.07 | $0.06 | $0.13 | $0.19 |
| EPS | $0.39 | $0.33 | $0.60 | $0.86 |
| Diluted EPS | $0.36 | $0.27 | $0.52 | $0.71 |
| Weighted Avg Shares Outstanding | $32.08M | $32.26M | $32.43M | $32.33M |
| Weighted Avg Shares Outstanding (Diluted) | $40.11M | $40.16M | $40.38M | $41.44M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan